Ectolysins Against Gram Positive Bacteria

Ectolysins against Staphylococcus: 
Ectolysin P128, GangaGen’s lead molecule is a chimeric recombinant anti-staphylococcal protein that targets both coagulase positive and coagulase negative Staphylococci. 
P128 has a novel mechanism of action and rapidly kills Staphylococci.
It is proven to be very effective both in vitro & in vivo against multidrug resistant pathogens like Methicillin Resistant Staphylococcus aureus (MRSA), Vancomycin Resistant Staphylococcus aureus (VRSA) and Daptomycin Resistant Staphylococcus aureus (DRSA). GangaGen has completed Phase I/IIA studies with P128 for ‘nasal decontamination of S. aureus’ from human nares.
	(Learn more about P128 here. Link  page)

Ectolysins against Enterococcus:
GangaGen has used PATP to discover and engineer novel ectolysins suitable for multiple applications.